Variable

N

All

Untreated

(n = 52)

Treated

(n = 168)

p

Age, year

220

53.6 ± 11.6

48.9 ± 12.2

55.1 ± 11.6

0.001

Gender, n (%)

220

0.121

M

115 (52.3)

23 (44.2)

92 (54.8)

F

105 (47.7)

29 (55.8)

76 (45.2)

Alcohol, n (%)

220

80 (36.5)

22 (43.1

58 (34.5)

0.170

Smoking, n (%)

220

28 (12.8)

6 (11.8)

22 (13.1)

0.509

Diabetes, n (%)

220

67 (30.5)

13 (25.0)

54 (32.1)

0.212

BMI, Kg/m²

220

28.9 ± 4.6

28.8 ± 5.0

28.9 ± 4.5

0.904

Obesity, n (%)

220

81 (36.8)

17 (32.7)

64 (38.1)

0.296

Dyslipidemia, n (%)

208

109 (49.5)

27 (51.9)

82 (48.8)

0.408

LVH, n (%)

214

88 (41.1)

17 (34.7)

71 (43.0)

0.191

Hypertensive retinopathy, n (%)

207

77 (37.2)

16 (34.0)

61 (38.1)

0.371

Office SBP, mm Hg

220

144.0 ± 20.4

144.6 ± 20.3

143.8 ± 12.9

0.814

Office DBP, mmHg

220

88.8 ± 13.0

89.3 ± 13.2

88.7 ± 13.0

0.762

24H ABPM SBP, mm Hg

220

133.0 ± 12.9

132.3 ± 10.9

133.2 ± 13.5

0.647

24H ABPM DBP, mm Hg

220

86.8 ± 10.3

85.8 ± 8.4

87.1 ± 10.9

0.425

Hb, g/dl

170

12.5 ± 1.6

12.6 ± 1.4

12.4 ± 1.7

0.414

Anemia, n (%)

170

24 (14.1)

4 (8.2)

20 (16.5)

0.117

HbA1c, %

41

7.1 ± 1.8

7.2 ± 2.6

7.1 ± 1.6

0.927

CRP, mg/l

213

5.0 ± 1.3

5.1 ± 1.2

5.0 ± 1.5

0.948

CRP > 3 mg/l, n (%)

213

121 (55.0)

38 (73.1)

83 (49.4)

0.002

TC, mg/dl

208

203.5 ± 41.9

205.0 ± 39.5

203.1 ± 42.8

0.774

LDL-c, mg/dl

208

130.7 ± 38.8

130.7 ± 37.5

130.6 ± 39.4

0.986

HDL-c, mg/dl

208

50.3 ± 14.7

53.9 ± 14.8

49.2 ± 14.5

0.049

TG, mg/dl

208

112.6 ± 37.5

105.3 ± 37.8

114.9 ± 37.2

0.111

FPG, mg/dl

163

99.4 ± 31.2

92.3 ± 22.5

102.3 ± 33.8

0.064

Creatinine, mg/dl

214

1.11 ± 0.8

1.15 ± 0.44

1.10 ± 0.53

0.693

eGFR, ml/min/1.73 m²

214

95.3 ± 36.8

97.9 ± 30.9

94.5 ± 38.5

0.568

eGFR < 60 ml/min/1.73 m²

214

36 (16.8)

5 (10.0)

31 (18.9)

0.101

Proteinuria, n (%)

210

74 (35.0)

16 (34.0)

58 (35.6)

0.495